Clinical Trial Update: Study Comparing High-Dose Flu Vaccine to Standard Vaccine in Cancer Patients Less Than 65 Receiving Chemotherapy [Phase 2]

View source ↗

Summary

Phase 2 trial comparing high-dose influenza vaccine to standard-dose influenza vaccine in cancer patients under 65 receiving chemotherapy; results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cancer

Drugs mentioned

• Fluzone (influenza vaccine)
• Fluzone High-Dose (Influenza vaccine, high-dose)

Snippet

Sponsor: Saad Jamshed MD | Conditions: Cancer, Influenza Viral Infections | Phase 2 | Status: COMPLETED | Results posted: 2016-05-24